New glucose monitor put to the test for accuracy

NCT ID NCT05806554

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed trial tested how accurately the True Vie I3 continuous glucose monitor measures blood sugar levels in 159 adults with type 1 or type 2 diabetes. Participants wore the device while researchers compared its readings to standard lab measurements. The goal was to see if the device meets FDA accuracy standards for integrated continuous glucose monitors.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Continuous glucose monitoring device
What this could lead to
If successful, this device could provide reliable, real-time glucose readings to help people with diabetes manage their condition more easily.
What could go wrong
This is a completed device accuracy study, not a treatment trial. Even if accurate, the device does not cure diabetes or replace standard care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Atlanta Diabetes Associates

    Atlanta, Georgia, 30318, United States

  • Diablo Clinical Research

    Walnut Creek, California, 94598, United States

  • Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm

    Ulm, D-89081, Germany

  • PSHI Praxis GmbH

    Mainz, 55128, Germany

  • Rainier Clinical Research Center

    Renton, Washington, 98057, United States

  • Woodland Research Northwest

    Rogers, Arkansas, 72758, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.